RT @CIR_AACR: Take a look at this perspective discussing #COVID19 and immune checkpoint blockade by @marinagarassino and AACR Past Presiden…

Take a look at this perspective discussing #COVID19 and immune checkpoint blockade by @marinagarassino and AACR Past President, Antoni Ribas! https://t.co/1BoYHoJab6 #AACR22 #SARSCoV2 #CIRReviewerStar ⭐ https://t.co/fO9WNZmYse

RT @khoney74: Fantastic #SITC21 talk from Jeff Webber @nyulangone giving a clinician's take on Coronavirus, Cancer, and Immunotherapy: Navi…

RT @khoney74: Fantastic #SITC21 talk from Jeff Webber @nyulangone giving a clinician's take on Coronavirus, Cancer, and Immunotherapy: Navi…

Fantastic #SITC21 talk from Jeff Webber @nyulangone giving a clinician's take on Coronavirus, Cancer, and Immunotherapy: Navigating Clinical Trials and Treatment. The @CIR_AACR Perspective from Toni Ribas and @marinagarassino he mentioned is here: https://

RT @Adri_CIR: About to watch #AACRtii21 session “COVID-19 Immunology in Cancer Patients”? Check out this @CIR_AACR perspective by #AntoniRi…

About to watch #AACRtii21 session “COVID-19 Immunology in Cancer Patients”? Check out this @CIR_AACR perspective by #AntoniRibas and @marinagarassino on #COVID19 and #ImmuneCheckpointBlockade. #SARSCoV2 #PD1 #PDL1 https://t.co/86l9FoluQl

#AAI2021 #ICYMI 👇👇

@UCCancerCenter

RT @Adri_CIR: #AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It d…

RT @Adri_CIR: #AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It d…

RT @Adri_CIR: #AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It d…

RT @Adri_CIR: #AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It d…

RT @Adri_CIR: #AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It d…

#AAI2021 Have a moment between sessions? Take a look at this @CIR_AACR perspective by #AntoniRibas and @marinagarassino! It discusses #COVID19 and #ImmuneCheckpointBlockade for cancer. #SARSCoV2 #PD1 #PDL1 👇👇 https://t.co/YuZPL8sw66

@martina_chirra @TMWiseDraper

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #…

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #…

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #…

Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #PD1 #PDL1 #AACR21 https://t.co/7sR4C4eJ0n https://t.co/7GJcfoInT7

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #…

Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #PD1 #PDL1 https://t.co/CUtGiLRfp8 https://t.co/5QqjJtMa0u

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2…

RT @CIR_AACR: Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2…

Check out this #COVID19 and #ImmuneCheckpointBlockade perspective by @AACRPres Antoni Ribas and @marinagarassino! #SARSCoV2 #PD1 #PDL1 https://t.co/RJ8YnccuCR https://t.co/QebIPHINoO

ICYMI— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer, by @AACRPres Antoni Ribas and @marinagarassino. #AACRCovid https://t.co/33QXvWU0Fg Visit the COVID and Cancer Resource Center for other free journal content. https://t.co/vpnt7h

RT @Adri_CIR: #ICYMI #AACRCovid #ImmuneCheckpoint #ICB #COVID19 https://t.co/PgGtbcg6kk

#ICYMI #AACRCovid #ImmuneCheckpoint #ICB #COVID19

RT @CIR_AACR: ICYMI— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer, by @AACRPres Antoni Ribas & @marinagarassino.…

ICYMI— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer, by @AACRPres Antoni Ribas & @marinagarassino. https://t.co/8JJjXj7r5Y Visit the COVID and Cancer Resource Center for other free journal content. https://t.co/KFGrZtrSi5 http

RT @CIR_AACR: ICYMI— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer, by @AACRPres Antoni Ribas & @marinagarassino.…

ICYMI— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer, by @AACRPres Antoni Ribas & @marinagarassino. https://t.co/I092Juy56H Visit the COVID and Cancer Resource Center for other free journal content. https://t.co/kVxVXMxWUg h

RT @AACRPres: I am grateful to @marinagarassino for collaborating with me on this outline of our current understanding of the consequences…

RT @CIR_AACR: ICYMI: https://t.co/q5dYBTobRm

ICYMI:

RT @AACRPres: I am grateful to @marinagarassino for collaborating with me on this outline of our current understanding of the consequences…

At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer. https://t.co/BOYv9durIh https://t.co/UfjwEELlTP

New article: At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer. https://t.co/FyvU8HkaqP #coronavirus #COVID19 #2019ncov https://t.co/AUzYvhl9vo

RT @khoney74: Thank you @marinagarassino and @AACRPres for contributing an article in this important topic https://t.co/ufA5JRt4Ad

RT @Adri_CIR: Just posted online! Check out this @CIR_AACR #COVID19 perspective by @AACRPres Antoni Ribas and @marinagarassino! #Immunother…

RT @marinagarassino: After about one year of pandemic there are no reasons to discontinue, delay, stop immune checkpoint inhibitors in canc…

RT @marinagarassino: After about one year of pandemic there are no reasons to discontinue, delay, stop immune checkpoint inhibitors in canc…

RT @AACRPres: I am grateful to @marinagarassino for collaborating with me on this outline of our current understanding of the consequences…

Thank you @marinagarassino and @AACRPres for contributing an article in this important topic

RT @marinagarassino: After about one year of pandemic there are no reasons to discontinue, delay, stop immune checkpoint inhibitors in canc…

RT @CIR_AACR: Just published #OnlineFirst— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer. Perspective by @AACRPres…

Important paper discussing crossroads between #COVID19 and #Immunotherapy for #cancer Must read not only for those treating #melanoma or #lungcancer #lcsm @AACRPres @marinagarassino

RT @marinagarassino: After about one year of pandemic there are no reasons to discontinue, delay, stop immune checkpoint inhibitors in canc…

After about one year of pandemic there are no reasons to discontinue, delay, stop immune checkpoint inhibitors in cancer patients. @AACR @OncoAlert

RT @CIR_AACR: Just published #OnlineFirst— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer. Perspective by @AACRPres…

Just posted online! Check out this @CIR_AACR #COVID19 perspective by @AACRPres Antoni Ribas and @marinagarassino! #Immunotherapy #ICB #PD1

I am grateful to @marinagarassino for collaborating with me on this outline of our current understanding of the consequences of receiving immune checkpoint inhibitor therapy during the #COVID19 pandemic.

Just published #OnlineFirst— At the Crossroads: #COVID19 and Immune Checkpoint Blockade for Cancer. Perspective by @AACRPres Antoni Ribas and @marinagarassino. https://t.co/NsNVJbaXhx https://t.co/CEHF1S1bYr